Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer

被引:6
作者
Lee, Erinna F. [1 ,2 ,3 ]
Fairlie, W. Douglas [1 ,2 ,3 ]
机构
[1] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia
[2] Olivia Newton John Canc Res Inst, Cell Death & Survival Lab, Heidelberg, Vic 3084, Australia
[3] La Trobe Univ, Sch Canc Med, Bundoora, Vic 3086, Australia
基金
英国医学研究理事会;
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; SELECTIVE SMALL-MOLECULE; STRUCTURE-GUIDED DESIGN; ANTI-APOPTOTIC MCL-1; BH3 MIMETIC ABT-737; X-L; CYTOCHROME-C; IN-VIVO; HIGH-AFFINITY; CELL-DEATH;
D O I
10.1042/BST20210749
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of a new class of small molecule compounds that target the BCL-2 family of anti-apoptotic proteins is one of the great success stories of basic science leading to translational outcomes in the last 30 years. The eponymous BCL-2 protein was identified over 30 years ago due to its association with cancer. However, it was the unveiling of the biochemistry and structural biology behind it and its close relatives' mechanism(s)-ofaction that provided the inspiration for what are now known as 'BH3-mimetics', the first clinically approved drugs designed to specifically inhibit protein-protein interactions. Herein, we chart the history of how these drugs were discovered, their evolution and application in cancer treatment.
引用
收藏
页码:2381 / 2395
页数:15
相关论文
共 50 条
[41]   MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer [J].
Zhang, H. ;
Li, Y. ;
Huang, Q. ;
Ren, X. ;
Hu, H. ;
Sheng, H. ;
Lai, M. .
CELL DEATH AND DIFFERENTIATION, 2011, 18 (11) :1702-1710
[42]   The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2 [J].
Li, Zhimei ;
Zhang, Yiyuan ;
Chen, Lixia ;
Li, Hua .
FOOD & FUNCTION, 2018, 9 (05) :3018-3027
[43]   Targeting BCL-2-like Proteins to Kill Cancer Cells [J].
Cory, Suzanne ;
Roberts, Andrew W. ;
Colman, Peter M. ;
Adams, Jerry M. .
TRENDS IN CANCER, 2016, 2 (08) :443-460
[44]   The BH3-only proteins BIM and PUMA are not critical for the reticulocyte apoptosis caused by loss of the pro-survival protein BCL-XL [J].
Delbridge, Alex R. D. ;
Aubrey, Brandon J. ;
Hyland, Craig ;
Bernardini, Jonathan P. ;
Di Rago, Ladina ;
Garnier, Jean-Marc ;
Lessene, Guillaume ;
Strasser, Andreas ;
Alexander, Warren S. ;
Grabow, Stephanie .
CELL DEATH & DISEASE, 2017, 8 :e2914-e2914
[45]   Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma [J].
Singh, Lata ;
Pushker, Neelam ;
Saini, Neeru ;
Sen, Seema ;
Sharma, Anjana ;
Bakhshi, Sameer ;
Chawla, Bhavna ;
Kashyap, Seema .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 (03) :259-267
[46]   Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues [J].
De Giorgi, M. ;
Voisin-Chiret, A. S. ;
Rault, S. .
CURRENT MEDICINAL CHEMISTRY, 2013, 20 (24) :2964-2978
[47]   Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival [J].
Eichhorn, Joshua M. ;
Alford, Sarah E. ;
Sakurikar, Nandini ;
Chambers, Timothy C. .
EXPERIMENTAL CELL RESEARCH, 2014, 322 (02) :415-424
[48]   Pro-apoptotic carboxamide analogues of natural fislatifolic acid targeting Mcl-1 and Bcl-2 [J].
Tiamas, Shelly Gapil ;
Daressy, Florian ;
Abou Samra, Alma ;
Bignon, Jerome ;
Steinmetz, Vincent ;
Litaudon, Marc ;
Fourneau, Christophe ;
Leong, Kok Hoong ;
Ariffin, Azhar ;
Awang, Khalijah ;
Desrat, Sandy ;
Roussi, Fanny .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (07)
[49]   Bcl-2 is required for cranial sensory neuron survival at defined stages of embryonic development [J].
Pinon, LGP ;
Middleton, G ;
Davies, AM .
DEVELOPMENT, 1997, 124 (20) :4173-4178
[50]   Bcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular Spheroids [J].
Yang, Tsung-Ming ;
Barbone, Dario ;
Fennell, Dean A. ;
Broaddus, V. Courtney .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2009, 41 (01) :14-23